Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Inflammatory Bowel Diseases
and you are
between 2 and 17
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Objectives: To assess the predictive value of IUS in children with IBD. Design: A prospective longitudinal cohort study. Setting: Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Hospital. Participants: Children 2 years to 17 years (up to 200 patients) who have been diagnosed with either CD or UC. Main outcome measures: The changes in bowel wall thickness, assessed by IUS, during 2-year follow-up according to therapeutic regimen. Secondary outcome measures: Correlation of sonographic measures to clinical disease indices, serum inflammatory and other laboratory markers, fecal calprotectin, endoscopic and other radiologic measures performed as part of routine care.

Provided treatments

  • Device: Intestinal ultra-sound monitoring
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03026582. The sponsor of the trial is Schneider Children's Medical Center, Israel and it is looking for 150 volunteers for the current phase.
Official trial title:
Intestinal Ultrasound Role in the Management of Pediatric Inflammatory Bowel Disease: A Prospective Longitudinal Cohort Study